We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-3 of 3

Awaited judgment from the ECJ on dissemination of information by an independent third party - it may be regarded as advertising

  • Bird & Bird
  • -
  • European Union
  • -
  • July 17 2009

On 2 April 2009 the ECJ interpreted Article 86 of Directive 200183EC definition of advertising for medicinal products

Comparative advertising of a generic medicine

  • Bird & Bird
  • -
  • France
  • -
  • December 15 2009

It is not necessary within the meaning of Article L. 713-6 of the French Intellectual Property Code (“CPI”) to mention the brand of the reference product in comparative advertising for a generic medicine, as the healthcare professionals to which the advertising is directed have other means (namely, the INN - international non-proprietary name) by which to identify the corresponding reference product

Court confirms that a press release to journalists amounts to prohibited advertising of pharmaceuticals

  • Bird & Bird
  • -
  • Sweden
  • -
  • May 22 2013

This article is a follow-up to an article in our March 2012 update concerning the decision of the Swedish Medical Products Agency (the "MPA"